title: Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer.
authors.affiliation: Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Aaron I
authors.initials: AI
authors.lastname: Loochtan
authors.affiliation: Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Myles S
authors.initials: MS
authors.lastname: Nickolich
authors.affiliation: Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Lisa D
authors.initials: LD
authors.lastname: Hobson-Webb
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D006801:Humans; D000074324:Ipilimumab; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000175:diagnosis*; D000077594:Nivolumab; D055752:Small Cell Lung Carcinoma / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab; D000077594:Nivolumab